Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

As per IR, quarterly report will

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
midastouch017 Member Profile
 
Followed By 126
Posts 25,638
Boards Moderated 9
Alias Born 02/07/04
160x600 placeholder
Oramed subsidiary to start clinical trials for its oral COVID-19 vaccine candidate Seeking Alpha - 7/21/2021 9:28:25 AM
Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial PR Newswire (US) - 7/21/2021 8:25:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 7/16/2021 4:16:12 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/15/2021 5:07:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/15/2021 4:16:49 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/14/2021 4:32:06 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 7/8/2021 4:30:49 PM
Oramed Pharmaceuticals to join Russell 2000 and 3000 Index Seeking Alpha - 6/22/2021 8:50:19 AM
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes PR Newswire (US) - 6/22/2021 8:40:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/16/2021 4:09:44 PM
Registration of Additional Securities (up to 20%) (s-3mef) Edgar (US Regulatory) - 6/16/2021 9:37:50 AM
Oramed Reaches 50% Enrollment in Phase 3 Oral Insulin Study PR Newswire (US) - 6/8/2021 8:10:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/25/2021 4:06:12 PM
Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 Vaccine PR Newswire (US) - 5/25/2021 8:40:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2021 4:16:04 PM
Oramed Pharmaceuticals and Oravax Medical to be Featured in Alliance Global Partners' Grand Rounds: A Webinar in Biotech and ... PR Newswire (US) - 4/21/2021 7:25:00 AM
Oramed Pharma initiated buy at Cantor citing the potential of oral insulin therapy Seeking Alpha - 4/20/2021 3:59:21 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/13/2021 4:20:14 PM
Oramed initiates second phase 3 study of oral insulin candidate; shares up 14% Seeking Alpha - 3/23/2021 9:39:49 AM
Oramed Initiates Second Phase 3 Oral Insulin Study Under the FDA's Approved Dual Concurrent Protocol PR Newswire (US) - 3/23/2021 8:51:00 AM
ORMP, MOGO, LIZI and LEAF among premarket gainers Seeking Alpha - 3/23/2021 8:23:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/23/2021 7:37:27 AM
Premas Biotech et Oramed annoncent un vaccin candidat oral contre la COVID-19 qui produit des anticorps après une seule dose Business Wire - 3/22/2021 3:06:00 AM
Premas Biotech and Oramed Announce Oral COVID-19 Vaccine Candidate That Produces Antibodies After a Single Dose Business Wire - 3/19/2021 10:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2021 9:07:51 AM
midastouch017   Monday, 04/12/21 11:09:16 AM
Re: Fmello post# 784
Post # of 940 
As per IR, quarterly report will
be issued tomorrow, Apr 13th.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences